Please enable JavaScript to continue using this application.

Compare $RLAY vs $VKTX | Chartloom

Compare

$RLAY vs $VKTX

Relay Therapeutics Inc · Viking Therapeutics Inc

RLAY

Relay Therapeutics Inc

VKTX

Viking Therapeutics Inc

Compare $RLAY vs $VKTX

Comparing Relay Therapeutics Inc and Viking Therapeutics Inc

RLAYRelay Therapeutics Inc

VKTXViking Therapeutics Inc

RLAYRelay Therapeutics Inc

Market cap

$3.85B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

610.65x

Rev growth (TTM)

23.9%

YTD performance

118.6%

52W performance

192.6%

FCF yield

-5.5%

VKTXViking Therapeutics Inc

Market cap

$3.33B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-19.5%

52W performance

-11.9%

FCF yield

-12.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RLAY

VKTX

Detailed metrics comparison

RLAY

Relay Therapeutics Inc

VKTX

Viking Therapeutics Inc

Market Cap

RLAY$3.85B

VKTX$3.33B

Enterprise Value

RLAY$3.73B

VKTX$3.20B

Price

RLAY$17.88

VKTX$28.51

P/E Ratio

RLAYN/A

VKTXN/A

P/S Ratio

RLAY372.39x

VKTX0.00x

EV/Sales

RLAY360.68x

VKTX0.00x

EV/EBITDA

RLAY0.00x

VKTX0.00x

P/B Ratio

RLAY4.67x

VKTX9.38x

P/FCF Ratio

RLAYN/A

VKTXN/A

EV/FCF

RLAY-17.59x

VKTX-7.65x

PEG Ratio

RLAYN/A

VKTXN/A

Forward P/E (NTM)

RLAYN/A

VKTXN/A

Forward P/S (NTM)

RLAY610.65x

VKTXN/A

Revenue (TTM)

RLAY$10M

VKTX$0

Revenue Growth (YoY)

RLAY23.9%

VKTXN/A

Forward Rev Growth

RLAY64.1%

VKTX236.5%

Gross Margin (TTM)

RLAY0.0%

VKTX0.0%

Operating Margin (TTM)

RLAY0.0%

VKTX0.0%

EBITDA Margin (TTM)

RLAY-2978.0%

VKTX0.0%

Net Margin (TTM)

RLAY-2763.6%

VKTX0.0%

FCF Margin (TTM)

RLAY-2050.3%

VKTXN/A

Net Income (TTM)

RLAY$-286M

VKTX$-535M

FCF (TTM)

RLAY$-212M

VKTX$-418M

EPS (TTM)

RLAY-$1.41

VKTX-$4.60

ROE (TTM)

RLAY-4227.0%

VKTX-9456.0%

ROA (TTM)

RLAY-3867.0%

VKTX-8274.0%

ROIC (TTM)

RLAY-4227.0%

VKTX-9456.0%

Cash

RLAY$121M

VKTX$126M

Debt

RLAY$0

VKTX$0

Net Cash/Debt

RLAY$121M

VKTX$126M

Current Ratio (TTM)

RLAY18.27x

VKTX4.72x

Quick Ratio (TTM)

RLAY18.10x

VKTX4.57x

Debt/Equity (TTM)

RLAY0.00x

VKTX0.00x

Debt/Assets (TTM)

RLAY0.0%

VKTX0.0%

Interest Coverage (TTM)

RLAYN/A

VKTXN/A

Net Debt/EBITDA (TTM)

RLAY0.00x

VKTX0.00x

Beta

RLAY1.71

VKTX0.69

52W Performance

RLAY192.6%

VKTX-11.9%

YTD Performance

RLAY118.6%

VKTX-19.5%

% from 52W High

RLAY-15.9%

VKTX-33.9%

% from 52W Low

RLAY205.6%

VKTX10.6%

Asset Turnover (TTM)

RLAY0.01x

VKTX0.00x

FCF Yield (TTM)

RLAY-5.5%

VKTX-12.6%

Earnings Yield (TTM)

RLAY-7.4%

VKTX-16.1%

Dividend Yield (TTM)

RLAYN/A

VKTXN/A

Rule of 40

RLAY-2,026.4

VKTX0.0

EV/GP/RG

RLAYN/A

VKTXN/A

Ticker research

View RLAY research View VKTX research

Metric	RLAY Relay Therapeutics Inc	VKTX Viking Therapeutics Inc
Market & Valuation
Market Cap	$3.85B	$3.33B
Enterprise Value	$3.73B	$3.20B
Price	$17.88	$28.51
P/E Ratio	N/A	N/A
P/S Ratio	372.39x	0.00x
EV/Sales	360.68x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.67x	9.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.59x	-7.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	610.65x	N/A
Revenue & Growth
Revenue (TTM)	$10M	$0
Revenue Growth (YoY)	23.9%	N/A
Forward Rev Growth	64.1%	236.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2978.0%	0.0%
Net Margin (TTM)	-2763.6%	0.0%
FCF Margin (TTM)	-2050.3%	N/A
Net Income (TTM)	$-286M	$-535M
FCF (TTM)	$-212M	$-418M
EPS (TTM)	-$1.41	-$4.60
ROE (TTM)	-4227.0%	-9456.0%
ROA (TTM)	-3867.0%	-8274.0%
ROIC (TTM)	-4227.0%	-9456.0%
Financial Health
Cash	$121M	$126M
Debt	$0	$0
Net Cash/Debt	$121M	$126M
Current Ratio (TTM)	18.27x	4.72x
Quick Ratio (TTM)	18.10x	4.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	0.69
52W Performance	192.6%	-11.9%
YTD Performance	118.6%	-19.5%
% from 52W High	-15.9%	-33.9%
% from 52W Low	205.6%	10.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-12.6%
Earnings Yield (TTM)	-7.4%	-16.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,026.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View RLAY research	View VKTX research

Valuation

P/S Ratio

VKTX

0.00x

RLAY

372.39x

EV/FCF

RLAY

-17.59x

VKTX

-7.65x

Growth & revenue

Revenue Growth TTM

RLAY

23.9%

Forward Revenue Growth

VKTX

236.5%

RLAY

64.1%

Profitability & performance

Gross Margin

RLAY

0.0%

VKTX

0.0%

ROE

RLAY

-4227.0%

VKTX

-9456.0%

FCF Yield %

RLAY

-5.5%

VKTX

-12.6%

52-Week Performance

RLAY

192.6%

VKTX

-11.9%

Detailed metrics comparison

RLAY

Relay Therapeutics Inc

VKTX

Viking Therapeutics Inc

Market Cap

RLAY$3.85B

VKTX$3.33B

Enterprise Value

RLAY$3.73B

VKTX$3.20B

Price

RLAY$17.88

VKTX$28.51

P/E Ratio

RLAYN/A

VKTXN/A

P/S Ratio

RLAY372.39x

VKTX0.00x

EV/Sales

RLAY360.68x

VKTX0.00x

EV/EBITDA

RLAY0.00x

VKTX0.00x

P/B Ratio

RLAY4.67x

VKTX9.38x

P/FCF Ratio

RLAYN/A

VKTXN/A

EV/FCF

RLAY-17.59x

VKTX-7.65x

PEG Ratio

RLAYN/A

VKTXN/A

Forward P/E (NTM)

RLAYN/A

VKTXN/A

Forward P/S (NTM)

RLAY610.65x

VKTXN/A

Revenue (TTM)

RLAY$10M

VKTX$0

Revenue Growth (YoY)

RLAY23.9%

VKTXN/A

Forward Rev Growth

RLAY64.1%

VKTX236.5%

Gross Margin (TTM)

RLAY0.0%

VKTX0.0%

Operating Margin (TTM)

RLAY0.0%

VKTX0.0%

EBITDA Margin (TTM)

RLAY-2978.0%

VKTX0.0%

Net Margin (TTM)

RLAY-2763.6%

VKTX0.0%

FCF Margin (TTM)

RLAY-2050.3%

VKTXN/A

Net Income (TTM)

RLAY$-286M

VKTX$-535M

FCF (TTM)

RLAY$-212M

VKTX$-418M

EPS (TTM)

RLAY-$1.41

VKTX-$4.60

ROE (TTM)

RLAY-4227.0%

VKTX-9456.0%

ROA (TTM)

RLAY-3867.0%

VKTX-8274.0%

ROIC (TTM)

RLAY-4227.0%

VKTX-9456.0%

Cash

RLAY$121M

VKTX$126M

Debt

RLAY$0

VKTX$0

Net Cash/Debt

RLAY$121M

VKTX$126M

Current Ratio (TTM)

RLAY18.27x

VKTX4.72x

Quick Ratio (TTM)

RLAY18.10x

VKTX4.57x

Debt/Equity (TTM)

RLAY0.00x

VKTX0.00x

Debt/Assets (TTM)

RLAY0.0%

VKTX0.0%

Interest Coverage (TTM)

RLAYN/A

VKTXN/A

Net Debt/EBITDA (TTM)

RLAY0.00x

VKTX0.00x

Beta

RLAY1.71

VKTX0.69

52W Performance

RLAY192.6%

VKTX-11.9%

YTD Performance

RLAY118.6%

VKTX-19.5%

% from 52W High

RLAY-15.9%

VKTX-33.9%

% from 52W Low

RLAY205.6%

VKTX10.6%

Asset Turnover (TTM)

RLAY0.01x

VKTX0.00x

FCF Yield (TTM)

RLAY-5.5%

VKTX-12.6%

Earnings Yield (TTM)

RLAY-7.4%

VKTX-16.1%

Dividend Yield (TTM)

RLAYN/A

VKTXN/A

Rule of 40

RLAY-2,026.4

VKTX0.0

EV/GP/RG

RLAYN/A

VKTXN/A

Ticker research

View RLAY research View VKTX research

Metric	RLAY Relay Therapeutics Inc	VKTX Viking Therapeutics Inc
Market & Valuation
Market Cap	$3.85B	$3.33B
Enterprise Value	$3.73B	$3.20B
Price	$17.88	$28.51
P/E Ratio	N/A	N/A
P/S Ratio	372.39x	0.00x
EV/Sales	360.68x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	4.67x	9.38x
P/FCF Ratio	N/A	N/A
EV/FCF	-17.59x	-7.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	610.65x	N/A
Revenue & Growth
Revenue (TTM)	$10M	$0
Revenue Growth (YoY)	23.9%	N/A
Forward Rev Growth	64.1%	236.5%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2978.0%	0.0%
Net Margin (TTM)	-2763.6%	0.0%
FCF Margin (TTM)	-2050.3%	N/A
Net Income (TTM)	$-286M	$-535M
FCF (TTM)	$-212M	$-418M
EPS (TTM)	-$1.41	-$4.60
ROE (TTM)	-4227.0%	-9456.0%
ROA (TTM)	-3867.0%	-8274.0%
ROIC (TTM)	-4227.0%	-9456.0%
Financial Health
Cash	$121M	$126M
Debt	$0	$0
Net Cash/Debt	$121M	$126M
Current Ratio (TTM)	18.27x	4.72x
Quick Ratio (TTM)	18.10x	4.57x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.71	0.69
52W Performance	192.6%	-11.9%
YTD Performance	118.6%	-19.5%
% from 52W High	-15.9%	-33.9%
% from 52W Low	205.6%	10.6%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.00x
FCF Yield (TTM)	-5.5%	-12.6%
Earnings Yield (TTM)	-7.4%	-16.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-2,026.4	0.0
EV/GP/RG	N/A	N/A
Ticker research	View RLAY research	View VKTX research